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Abstract The NusB protein is involved in transcriptional 
regulation in bacteriophage λ. NusB binds to the RNA form of 
the nut site and along with N, NusA, NusE and NusG, stabilizes 
the RNA polymerase transcription complex and allows stable, 
persistent antitermination. NusB contains a 10 residue Arg-rich 
RNA-binding motif (ARM) at the N-terminus but is not 
sequentially homologous to any other proteins. In contrast to 
other known ARM-containing proteins, NusB forms a stable 
structure in solution in the absence of RNA. NMR spectroscopy 
was used to determine that NusB contains six a-helices: R10-
Q21, I27-F34, V45-L65, Q79-^S93, Y100-F114 and D118-
L127. The structure of NusB makes it a member of a newly 
emerging class of «-helical RNA-binding proteins. 
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1. Introduction 
One of the mechanisms of transcriptional regulation in bac-
teriophage λ is transcriptional antitermination, a process in 
which genes whose expression would be prematurely termi-
nated are activated by termination suppression. In phage λ, 
genome-specific protein antiterminators convert RNA polym-
erase (RNAP) into a termination-resistant form during the 
early stages of elongation [1-3]. The N protein and host fac-
tors NusA, NusB, NusE and NusG associate with RNAP and 
the RNA form of the nut site {nut = BoxA+BoxB) to form a 
stable ribonucleoprotein (RNP) complex. This complex trav-
els along the DNA distal to the nut site and allows transcrip-
tion past potential termination sites [2]. A basal level of anti-
termination occurs with only the N and NusA proteins 
associated with the RNAP/nucleic acid complex [3,4]. How-
ever, stable, persistent antitermination requires the presence of 
the NusB, NusE and NusG factors as well [5]. 
NusB is a 16 kDa protein that binds selectively to BoxA of 
the nascent mRNA transcript as a heterodimer with the NusE 
protein [6,7]. A recent genetic study suggested that NusB in-
teracts with BoxA RNA and that NusE is indirectly associ-
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ated with the RNA [8]. This interaction of NusB with BoxA 
RNA is important, since a deletion of or mutations within 
BoxA that prevents the association of NusB/NusE with 
BoxA RNA also impairs antitermination [7]. The significance 
of NusB is also demonstrated by double-mutation studies in 
which a NusB mutant (nusBlOl) that can overcome suppres-
sion of antitermination caused by a NusA mutant (nusAl) 
requires BoxA RNA for this suppression [9]. One of the func-
tions of NusB is to provide stabilization to the RNP antiter-
mination complex and allow transcription farther downstream 
than in the absence of the Nus cofactors. It has also been 
shown that NusB counteracts an inhibitory factor in the cell 
that binds to the nut region [8]. The function of NusB would 
then be to compete with this cellular inhibitor for binding to 
BoxA and allow normal function of the antitermination com-
plex. NusB has also been found to form a complex with ri-
bosomal BoxA RNA and NusE, and may be involved in 
ribosomal RNA synthesis [2,7]. 
Structural details of RNA-binding proteins have lagged be-
hind those of DNA-binding proteins. Several RNA-binding 
motifs have been identified in proteins with widely varied top-
ology (reviewed in [10-12]). Many RNA-binding proteins 
carry multiple copies of a motif or contain several different 
motifs. Most sequence motifs for RNA-binding proteins have 
a mixed αβ structural topology. For example, the RNP motif 
has a βαββαβ topology [13-19] while the KH motif has a 
βααββα topology [20,21]. The double stranded RNA-binding 
(dsRNA) motif has an αβββα topology [22,23] and there are 
also RNA-binding motifs similar to the DNA-binding Zn-fin-
ger motif [24]. Another motif, the RGG box, is an Arg-Gly-
Gly tripeptide repeated many times within the protein se-
quence [25,26] for which little is known about the structure. 
The Arg-rich RNA-binding motif (ARM) consists of small 
regions of the protein (10-20 amino acids) with a predomi-
nance of Arg residues. The sequence and structure of the 
ARM region in different proteins vary widely [27]. For exam-
ple, the ARM region of BIV tat (ALGISYGRKK-
RRQRRRP) binds RNA as a ß hairpin [28,29] whereas the 
ARM region of the Rev protein (TRQARRNRRRRW-
RERQ) binds RNA as an a-helix [30]. Many of the ARM 
proteins are unfolded in the absence of RNA and adopt a 
folded conformation upon binding [28,31,32]. A final example 
of topological variability is the recently identified SI motif 
that forms a 5-stranded ß-barrel [33]. 
The NusB protein contains an ARM motif but does not 
contain any other of the above mentioned motifs. NusB is 
not sequentially homologous to any known proteins based 
on a Basic Local Alignment Search Tool (BLAST) search 
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[34]. In this paper, we show that in contrast to the other A R M 
proteins, NusB adopts a stable, folded structure in solution in 
the absence of R N A , with the exception of the A R M region 
itself (residues 1-10). We have determined the structure of 
NusB to be cc-helical, which puts it into a class of RNA-bind-
ing proteins [35-37] that define a new, oc-helical structural 
motif. 
2. Materials and methods 
2.1. Sample preparation 
NusB was cloned into the pJL6 plasmid vector containing the pL 
promoter. The construct was transformed into NC198 cells that are 
N + and contain a temperature-sensitive repressor [1]. The transformed 
cells were grown in M9 minimal medium [38] supplemented with bio-
tin, thiamine and 100 μg/ml carbenicillin. Preinduction growth was 
done at 32°C to an OD60o of 0.6-0.9 and cells were then induced at 
42°C for 4 h. The harvested cells were homogenized in 8 M urea, 50 
mM sodium phosphate and 20 mM dithiothreitol (DTT) at pH 6.8. 
The lysate was stirred for ~ 12 h at 4°C. The sample was centrifuged 
and the protein was isolated from the soluble fraction by FPLC using 
a 0-0.5 M NaCl gradient (with 8 M urea, 50 mM phosphate and 10 
mM DTT at pH 6.8) on a HiLoad Sepharose SP cation exchange 
column. The NusB protein was then refolded by dialysis against de-
creasing amounts of urea in phosphate buffer. The protein was chro-
matographed on the same cation exchange column using the gradient 
described above without urea but with 5 mM DTT. The purified 
protein was then concentrated to final NMR sample concentrations 
of 1.0-1.5 mM in 50 mM sodium phosphate, 0.1 M NaCl and 2 mM 
DTT at pH 6.8. Isotopically labeled samples were prepared using the 
method described above except that 15NH4C1 (99.9% 15N, Isotec), 
13C6-glucose (99% 13C, Isotec), D7-glucose (98% D, Cambridge Iso-
tope Laboratories, Inc.) and D 2 0 (99.8% D, Isotec) were substituted 
as required. 
The purity of the NusB preparation was verified using mass spec-
trometry, amino acid analysis and protein sequencing. The extent of 
isotopic label incorporation was 99.0% 15N, 99.9% 13C, 15N and 
99.94% 2H, 15N. The NusB protein produced by the above protocol 
is in its native conformation as shown by wild-type activity in an in 
vitro antitermination assay (A. Das, personal communication). The 
protein concentration was determined by amino acid analysis and UV 
absorbance at 280 nm. The extinction coefficient (ε28ο) was determined 
to be 8.03 m M - 1 cm"1. 
2.2. Circular dichroism (CD) 
The CD spectrum was recorded on a Jasco 720 spectropolarimeter. 
The protein sample was 10.4 μΜ in 50 mM phosphate buffer with 
2 mM DTT. Spectra were recorded from 180 to 260 nm using a 
0.1 mm path length demountable cell (Uvonics) at 22°C. Ellipticity 
was calculated per residue. 
2.3. NMR spectroscopy 
All spectra were recorded on a 600 MHz Varían Unity Plus spec-
trometer equipped with triple-resonance pulsed field gradient (PFG) 
probes (Nalorac Corporation). An 8 mm diameter probe and sample 
was used for enhanced sensitivity in all of the sequential assignment 
experiments and in the 4D HMQC-NOESY-HSQC experiment. A 
5 mm probe and sample was used in all of the other experiments. 
'H-1SN HSQC: Standard HSQC spectra were run using flipback 
pulses [39] and WATERGATE [40] for solvent suppression. 
WATERSLED: Self-diffusion measurements of 1.2 mM NusB in 
90% H2O/10% D 2 0 were made using the WATERSLED sequence 
described in [41]. PFG calibration was carried out as described there-
in. The PFG strength was arrayed in 32 steps from 4 to 42 G/cm. The 
diffusion time was 134 ms and 128 transients were collected with a 
recycle delay of 10 s. Data were processed in Felix 2.30 (Biosym 
Technologies, Inc.). The MLAB program (Civilized Software, Inc.) 
was used to fit the integrated intensities (aliphatic region excluding 
peaks from excess DTT) to an exponential curve from which the self-
diffusion coefficient Ds was obtained. The goodness of fit was deter-
mined by calculating the residual error of the experimental data to the 
fit curve. 
CBCA(CO)NH, HNCACB, C(CO)NH and H(CCO)NH: The tri-
ple-resonance sequential assignment experiments were run using PFG-
coherence selection pulse sequences with sensitivity enhancement [42]. 
Spectral details are shown in Table 1. Sequential assignments were 
made using Ansig 3.2 software [43,44] and were assisted by the assign-
ment probability program of Grzesiek and Bax [45]. Side chain XH 
and 13C assignments were made using the 3D triple resonance 
C(CO)NH and H(CCO)NH experiments [42] and a 3D HCCH-
TOCSY experiment [46]. The sample for the HCCH-TOCSY experi-
ment was 1.3 mM in 100% D 2 0 . 
3JHNHA : The 3JHNHA coupling constants were measuring from a 3D 
HNHA experiment and the backbone dihedral angle, φ, was calcu-
lated using the modified Karplus equation [47]. The data were proc-
essed and analyzed using Felix 95 (Biosym Technologies, Inc.). 
HN exchange: Amide exchange information was obtained by dis-
solving a lyophilized NusB sample into fresh 99.9% D 2 0 (Sigma) and 
observing the decrease in amide (NH) signals in a series of !H-1 5N 
HSQC experiments over 24 h. The first spectrum was obtained 10 min 
after dissolving the sample in D 2 0 . 
Nuclear Overhauser effect spectroscopy (NOESY): The following 
experiments were analyzed to obtain short-range NOEs indicative of 
secondary structure: a 3D 15N-edited NOESY-HSQC [48], Tmix = 125 
ms on 1.2 mM 15N-NusB, a 4D (C/N) HMQC-NOESY-HSQC [49], 
Tmix = 100 ms on 1.5 mM 13C,15N-NusB, and a 4D (N/N) HSQC-
NOESY-HSQC experiment [50,51], xmix = 200 ms on a 1.7 mM 
2H,15N-NusB sample. Flipback pulses and WATERGATE were 
used for solvent suppression in each of the NOESY experiments. 
Additional spectral parameters are shown in Table 1. 
3. Results 
3.1. Solution state characterization 
The C D spectrum of NusB is shown in Fig. 1. A maximum 
at 191 nm and minima at 208 and 222 n m are consistent with 
cc-helical secondary structure. The amplitude of the maximum 
is 65000 deg cm2 d m o l - 1 and the amplitudes of both minima 
are —28 000 deg cm2 d m o l - 1 . This spectrum corresponds to a 
folded protein with 80-85% oc-helicity [52]. 
The NusB protein exists in solution as a monomer under 
N M R conditions. The monomeric state is confirmed by N M R 
P F G self-diffusion measurements, which are consistent with 
results from relaxation and line width measurements for a 
16 k D a protein. The resulting self-diffusion coefficient, D s , 
of 1.01 X 10~6 cm2 s _ 1 corresponds to a monomer of NusB, 
by comparison to the D s of two proteins of related size (ly-
sozyme, 14.1 kDa, D s = 1.04X 10~6 cm2 s" 1 ; monocyte chemo-
tactic protein (MCP-1), 17.4 k D a dimer, D s = 1.08 X 10"6 cm2 
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Fig. 1. The CD spectrum of 10.4 μΜ NusB in 50 mM phosphate 
buffer at pH 6.8 and 2 mM DTT. The data are consistent with 80-
85% a-helicity [52]. 
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Table 1 
Acquisition parameters for the NMR experiments 
Experiment Sample Nucleus Complex time 
domain pts. 
Spectral width (Hz) 
Fl F2 F3 F4 tl il t3 t4 swl sw2 sw3 sw4 
Mix # Expt. 
time scans time 
(ms) (h) 
CBCA(CO)NH [42] 
HNCACB [42] 
C(CO)NH [42] 
H(CCO)NH [42] 
HCCH-TOCSY [46] 
HNHA [47] 
NOESY-HSQC [48] 
HMQC-NOESY-HSQC [49] 
HSQC-NOESY-HSQC [50,51] 
1.3 mM 
13 C ; 15 N 
1.3 mM 
13C,16N 
1.3 mM 
13Q1BN 
1.3 mM 
13C,16N 
1.3 mM 
13C,16N 
1.0 mM 
15 N 
1.0 mM 
16 N 
1.3 mM 
13C,16N 
1.7 mM 
2 j j l 5 N 
50 32 1024 
50 32 1024 
50 32 1024 
54 32 1024 
128 48 1024 
64 32 1024 
128 32 512 
9259.3 1479.3 7504.7 
9259.3 1479.3 7504.7 
9259.3 1479.3 7504.7 
3876.0 1479.3 7504.7 
3600.0 3021.1 6504.1 
4200.0 1479.3 7504.7 
7518.8 2433.1 7523.0 
22.8 
23.5 
22.8 
25 
00 
00 
32 
32 
32 
32 
8 
28 
4 
4 
4 
63 
63 
63 
68 
60 
70 
41 
136 
164 
m 
H Q54 -G115 
|©] M66 Ξ 
S93 
♦ - N 1 3 7 
w 
»S23" 
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Fig. 2. ΧΗ-15Ν HSQC spectrum of 1.7 mM 2H,15N-NusB in 90% H2O/10% D 2 0 at 600 MHz. Acquisition parameters: *H sweep = 7504.7 Hz, 
acquisition time= 136 ms, selective pulse for WATERGATE suppression scheme= 1.0 ms, flipback pulse = 2.5 ms, 4 scans per tl increment, 128 
tl increments, 15N sweep = 1479.3 Hz and States-TPPI [60] for quadrature in t l . Spectra were processed using NMRPipe [61]. Data were proc-
essed using time-domain solvent subtraction and were zero-filled and multiplied by a 90°-shifted squared sine-bell before Fourier transforma-
tion. 
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Fig. 3. Summary of secondary structure results for NusB. NOEs shown are a sum of NOEs found between backbone atoms (HN-HN, Ha-HN 
and Ηβ-ΗΝ) of the indicated residues. Downward triangles are shown for residues with 3JHNHA < 6 HZ and upward triangles for residues with 
3JHNHA > 8 Hz. Amide exchange results are also shown. Closed circles are for residues whose backbone HN is in slow exchange (still present 
after 24 h in D2O solvent). Half-filled circles are shown for residues whose backbone HN is in intermediate-slow exchange (present after 2 h, 
but exchanged by 24 h). No symbol is indicated for residues whose HN had exchanged within 30 min. Helical symbols are shown above the se-
quence for regions that are determined to be ot-helical based on the above data. 
s ) and to a larger protein that would be approximately the 
size of a NusB dimer (interleukin-10, 37.4 kDa dimer, 
D s = 0 . 8 2 x l 0 " 6 cm2 s"1) [41]. Furthermore, the excellent fit 
of the experimental data to a single exponential curve sup-
ports the conclusion of a single, monomeric species in solu-
tion. 
3.2. Sequential assignments 
The 1H-15N heteronuclear single quantum correlation spec-
trum (HSQC) of perdeuterated NusB is shown in Fig. 2. The 
spectrum shows good chemical shift dispersion for the back-
bone amides (NH) of a 139 residue (16 kDa) protein. This 
dispersion as well as redundancy in the five 3D spectra used 
for sequential assignments yield complete, unambiguous as-
signments for the majority of the protein. The backbone 
amide cross peaks are labeled with their sequential assign-
ments in Fig. 2. The side chain amides (NH2) of the 11 Asn 
and Gin residues in NusB are shown as connected peaks. The 
Arg side chain Νε-Ηε have been assigned for R49 and R95. 
The unlabeled folded cross peaks (boxed = folded peak) in 
Fig. 2 are from four additional Arg side chain Νε-Ηε. The 
amide resonances V43, D44, S71, and H120 as well as for the 
ARM region, residues M1-R10, are not observed. The ab-
sence of these peaks is probably due to exchange broadening 
on an intermediate ( ~ ms) time scale which can be caused by 
solvent exchange or conformational variability [53]. The re-
maining backbone and side chain resonance assignments for 
*H, 13C and 15N nuclei have been completed and will be 
presented subsequently. 
3.3. Secondary structure 
Identification of secondary structure from NMR data takes 
advantage of several observable characteristics. With the com-
plete sequential assignments, chemical shift differences from 
random coil values, Δδ, are calculated for the protein. The 
chemical shifts of Coc, Cß, C and Ha nuclei are particularly 
sensitive to secondary structure in predictable ways [54-56]. 
Fig. 3 shows the measured Δδ for the Cot and Ha nuclei of 
NusB. The Δδ for Ca are downfield from random coil values 
and those for Ha are upfield from random coil values, con-
sistent with a primarily a-helical secondary structure. 
Backbone dihedral angles were obtained for the well-re-
solved HN to Ha resonances of NusB and are shown as 
3JHNHA in Fig. 3. Downward arrows are shown for 52 residues 
whose 3JHNHA < 6 Hz, corresponding to residues in a-helices 
(φ~—60°). Upward arrows are shown for 14 residues whose 
3JHNHA > 8 Hz, corresponding to residues in a more extended 
or β conformation (φ~120°). These results show that much 
more a-helical secondary structure, rather than ß-strand, is 
present in NusB. 
A clear indication of secondary structure is found by ob-
serving patterns of nuclear Overhauser enhancements (NOEs) 
that correspond to distances between backbone protons of 
non-sequential residues. Sequential series of (i,i+2), (i,i+3) 
and (i,i+4) NOEs are observed in a-helices [53], those found 
for NusB are summarized in Fig. 3. Several regions have 
daN(i,i+3) NOEs and measurable dNN(i,i+2), dNN(i,i+3) 
and daN(i,i+4) NOEs indicative of stable a-helices. 
Slowly exchanging amide protons are often found in re-
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gions of stable secondary structure, bo th a-helices and ß-
sheets. The N H protons that did not exchange to deuterons 
within 2 h of dissolving a freshly lyophilized sample into D2O 
are indicated by half-filled circles in Fig. 3 while those that 
had not exchanged by 24 h are shown as closed circles. 
By combining the chemical shift index, 3JHNHA, identifica-
tion of slowly exchanging amide protons and patterns of 
NOEs , we have identified six a-helices in NusB. The a-helices 
extend from R10-Q21 (helix A), I27-F34 (helix B), V45-L65 
(helix C), Q79-S93 (helix D), Y100-F114 (helix E) and D 1 1 8 -
L127 (helix F) and are shown schematically above the amino 
acid sequence in Fig. 3. The direction of δΔ for N59, the large 
3JHNHA for T57 and N58 and the absence of (i,i+3) N O E s 
originating on A56 or T57 indicate a break in helical structure 
at T57-T59. This kink in helix C will be further characterized 
during structural refinement. 
4. Discussion 
The NusB RNA-binding antitermination protein is a folded 
protein containing six a-helices in solution. The a-helical 
structure of NusB determined by N M R is consistent with 
the C D spectrum as well as with secondary structure predic-
tion methods based on the amino acid sequence [57]. These 
results show that NusB is different from some other A R M 
proteins such as N [32], N u n [58] and homeodomain /DNA 
[31] that are entirely unfolded when not bound to R N A and 
then fold upon binding to R N A . In NusB, only the A R M 
region (residues 1-10) seems to lack an ordered structure, 
while the rest of the protein forms a stable structure. The 
lack of observable resonances for residues 1-10 in the absence 
of R N A suggests that a conformational change or stabiliza-
tion may take place in the A R M region of NusB when it 
binds to R N A . The significance of the NusB structure in the 
absence of R N A , in terms of understanding its binding to 
R N A , is not obvious. However, proteins or peptides contain-
ing A R M regions that are unfolded in the absence of R N A do 
exhibit specific binding to R N A . This observation makes it 
likely that binding also involves some of the remaining protein 
scaffold [59]. The inclusion of residues outside the A R M re-
gion as part of the binding surface could also explain differ-
ences in the binding specificity of the A R M region, whose 
amino acid sequences vary widely in different proteins. 
Three-dimensional structure determination of NusB is in 
progress in our laboratory and should provide insight into 
the presentation of the A R M region to R N A . Studies of 
NusB in the presence of BoxA R N A are also under way 
and may provide insight into the specificity of the protein-
R N A interaction as well as determine whether the A R M re-
gion alone is responsible for binding or whether other parts of 
the NusB protein are also involved. 
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